Examination of the potential long-lasting protective effect of ICRF-187 against anthracycline-induced chronic cardiomyopathy
- 30 September 1990
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 17 (2-3) , 155-160
- https://doi.org/10.1016/0305-7372(90)90040-m
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast CancerNew England Journal of Medicine, 1988
- Doxorubicin Cardiotoxicity: Assessment of Late Left Ventricular Dysfunction By Radionuclide CineangiographyAnnals of Internal Medicine, 1981
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979
- Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease.Clinical evaluation with special reference to childhood leukemiaCancer, 1967